Sunpeaks Ventures Signs Advertising and Promotion Agreement With Another Major Sports Team - Clotamin To Be Sold at All Walgreens Locations Throughout Arizona

SILVER SPRING, Md., April 13, 2012 /PRNewswire/ -- Sunpeaks Ventures, Inc. (OTCBB: SNPK) (PINKSHEETS: SNPK) (the "Company" or "Sunpeaks Ventures") and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS") are pleased to announce that HDS has entered into an advertising and promotion agreement ("Agreement") with a major pro sports team based in the state of Arizona (the "Team") for the marketing of Clotamin.  The Agreement is part of new marketing initiatives to promote and launch Clotamin in 240 Walgreens throughout Arizona.

Under terms of the Agreement, HDS, in conjunction with Walgreens, will have the right to make use of the Team name and logo in connection with an in-store Clotamin promotion, including the prominent placement of counter point-of-sale (POS) displays in all Walgreens locations in the state of Arizona for the duration of the promotion – approximately five months, beginning on June 1, 2012. 

During the consumer promotion and advertising program, Clotamin will be featured at Team home games on signage and other marketing elements throughout the University of Phoenix Stadium in Glendale, Arizona.  Team fans will be encouraged to visit their local Walgreens location, pick-up an entry form at the Team vendor display, and register for the opportunity to experience a Team home game in the comfort of an exclusive private box.  One lucky winner each month (4 total) will receive a private box for a Team home game, including game tickets, VIP parking passes, and a food and beverage package for 16 guests.  Also included in the exclusive prize package experience is special personal appearance by the Team mascot/cheerleaders and 16 team gift bags. 

"Similar to our pro sports team deal to market Clotamin with Walgreens in Oregon, this new agreement in Arizona is designed to leverage our advertising capabilities to grow awareness and acceptance of Clotamin with strong endorsements and strategic sponsorships," stated Mackie A. Barch, CEO of Sunpeaks Ventures. "The marketing combination of pharmacy powerhouse Walgreens and a highly-recognizable pro sports team is designed to allow us to quickly introduce Clotamin to a statewide audience of loyal customers and fans.  We look forward to working closely with Walgreens and the Team to make this a successful product launch and an unforgettable experience for our contest winners."

About Sunpeaks Ventures, Inc.

Sunpeaks Ventures, Inc. and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS"), is a nationally focused, value-added distributor of specialty drugs and over-the-counter ("OTC") branded multivitamins to the healthcare provider market.   HDS also owns and markets Clotamin®, a specialized over-the-counter multivitamin product designed exclusively for use by patients also on Warfarin®, a popular blood thinner that has a long list of known adverse drug and food interactions.

For additional information, please visit www.sunpeaksventures.com.

Contact: Financial Insights 888-248-8491 or [email protected]

Safe Harbor Statement

Information in this document constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  The words "forecast", "anticipate", "estimate", "project", "intend", "expect", "should", "believe", and similar expressions are intended to identify forward-looking statements.  These forward-looking statements involve, and are subject to known and unknown risks, uncertainties and other factors which could cause Sunpeaks Ventures' actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements.  The risks, uncertainties and other factors are more fully discussed in Sunpeaks Ventures' filings with the U.S. Securities and Exchange Commission.  All forward-looking statements attributable to Sunpeaks Ventures herein are expressly qualified in their entirety by the above-mentioned cautionary statement.  Sunpeaks Ventures disclaims any obligation to update forward-looking statements contained in this estimate, except as may be required by law.

SOURCE Sunpeaks Ventures, Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED